Massachusetts Financial Services’s Immunocore IMCR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $14M | Sell |
445,767
-14,984
| -3% | -$470K | ﹤0.01% | 654 |
|
|
2025
Q1 | $13.7M | Buy |
460,751
+1,706
| +0.4% | +$50.6K | ﹤0.01% | 633 |
|
|
2024
Q4 | $13.5M | Sell |
459,045
-39,176
| -8% | -$1.16M | ﹤0.01% | 634 |
|
|
2024
Q3 | $15.5M | Buy |
498,221
+107,656
| +28% | +$3.35M | ﹤0.01% | 618 |
|
|
2024
Q2 | $13.2M | Buy |
390,565
+79,444
| +26% | +$2.69M | ﹤0.01% | 618 |
|
|
2024
Q1 | $20.2M | Sell |
311,121
-1,487
| -0.5% | -$96.7K | 0.01% | 573 |
|
|
2023
Q4 | $21.4M | Buy |
312,608
+261
| +0.1% | +$17.8K | 0.01% | 562 |
|
|
2023
Q3 | $16.2M | Sell |
312,347
-49,616
| -14% | -$2.58M | 0.01% | 586 |
|
|
2023
Q2 | $21.7M | Sell |
361,963
-3,619
| -1% | -$217K | 0.01% | 543 |
|
|
2023
Q1 | $18.1M | Sell |
365,582
-352
| -0.1% | -$17.4K | 0.01% | 563 |
|
|
2022
Q4 | $20.9M | Buy |
365,934
+1,196
| +0.3% | +$68.3K | 0.01% | 544 |
|
|
2022
Q3 | $17.1M | Buy |
364,738
+24,796
| +7% | +$1.16M | 0.01% | 570 |
|
|
2022
Q2 | $12.7M | Sell |
339,942
-2,536
| -0.7% | -$94.6K | ﹤0.01% | 592 |
|
|
2022
Q1 | $10.2M | Buy |
342,478
+9,398
| +3% | +$281K | ﹤0.01% | 633 |
|
|
2021
Q4 | $11.4M | Sell |
333,080
-2,432
| -0.7% | -$83.3K | ﹤0.01% | 652 |
|
|
2021
Q3 | $12.4M | Buy |
335,512
+238,286
| +245% | +$8.83M | ﹤0.01% | 658 |
|
|
2021
Q2 | $3.8M | Sell |
97,226
-276
| -0.3% | -$10.8K | ﹤0.01% | 728 |
|
|
2021
Q1 | $4.15M | Buy |
+97,502
| New | +$4.15M | ﹤0.01% | 707 |
|